Advertisement

Ischemic tolerance of rat hearts in acute and chronic phases of experimental diabetes

  • Táňa Ravingerová
  • Jan Neckář
  • František Kolář
Part of the Developments in Molecular and Cellular Biochemistry book series (DMCB, volume 42)

Abstract

Different from clinical studies of diabetes mellitus (DM), experimental data reveal both, higher and lower vulnerability of the heart to ischemic injury. We have previously demonstrated an enhanced resistance to ischemia-induced arrhythmias in isolated rat hearts in the acute phase of DM. Our objectives were thus to extend our knowledge to the effects of DM of different duration on myocardial infarction, in conjunction with susceptibility to arrhythmias, in the in vivo model. DM was induced by streptozotocin (45 mg/kg, i.v.) and following 1 week (acute phase) and 8 weeks (chronic phase), anesthetized open-chest diabetic and age-matched control rats were subjected to 30-min regional ischemia (occlusion of LAD coronary artery) followed by 4-h reperfusion for the evaluation of the infarct size (tetrazolium staining). In the control rats, ventricular tachycardia (VT) represented 45.4% of total arrhythmias and occurred in 90% of the animals. In the acute phase of DM, arrhythmia profile was similar to that in the control animals, and the incidence and severity of arrhythmias were not enhanced. On the other hand, the size of infarct area normalized to the size of area at risk was significantly smaller in the diabetics than in the controls (47.2 ± 2.8 vs. 70.2 ± 2.1%, respectively; p < 0.05). In the chronic phase, only 17.7% of arrhythmias occurred as VT in 44% of the diabetics (p < 0.05 vs. controls). Severity of arrhythmias was also lower (arrhythmia score: 2.1 ± 0.3 vs. 2.9 ± 0.3 in the controls, respectively; p < 0.05). This effect was not due to a smaller infarct size, since the latter did not differ from that in the controls. In conclusion: diabetic rat hearts exhibit rather lower, than higher sensitivity to ischemia. In acute phase of DM, diabetic hearts are more resistant to irreversible cell damage, whereas in the chronic phase they exhibit reduced susceptibility to arrhythmias; these discrepancies might reflect different pathogenesis of arrhythmias and myocardial infarction. (Mol Cell Biochem 249: 167–174, 2003)

Key words

experimental diabetes myocardial ischemia arrhythmias infarction rat heart 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Kannel WB, McGee DL: Diabetes and cardiovascular risk factors. The Framingham Study. Circulation 59: 8–13, 1979PubMedCrossRefGoogle Scholar
  2. 2.
    Malmberg K, Ryden L: Myocardial infarction in patients with diabetes mellitus. Eur Heart J 9: 259–264, 1988PubMedGoogle Scholar
  3. 3.
    Garratt KN, Brady PA, Hassinger NL, Grill DE, Terzic A, Holmes DR: Sulphonylureas drugs increase early mortality in patients with diabetes mellitus after direct angioplasty for acute myocardial infarction. J Am Coll Cardiol 33: 119–124, 1999PubMedCrossRefGoogle Scholar
  4. 4.
    Dhalla NS, Liu X, Panagia V, Takeda A: Subcellular remodeling and heart dysfunction in chronic diabetes. Cardiovasc Res 40: 239–247, 1998PubMedCrossRefGoogle Scholar
  5. 5.
    Forrat R, Sebbag L, Wiensperger A, Guidollet J, Delaye J, De Lorgeril M: Acute myocardial infarction in diabetic dogs with experimental diabetes. Cardiovasc Res 27: 1908–1912, 1993PubMedCrossRefGoogle Scholar
  6. 6.
    Hadour G, Ferrera R, Sebbag L, Forrat R, Delaye J, De Lorgeril M: Improved myocardial tolerance to ischemia in the diabetic rabbit. J Mol Cell Cardiol 30: 1869–1875, 1998PubMedCrossRefGoogle Scholar
  7. 7.
    Liu Y, Thornton JD, Cohen MV, Downey JM, Schaffer SW: Streptozotocin-induced non-insulin dependent diabetes protects the heart from infarction. Circulation 88: 1273–1278, 1993PubMedCrossRefGoogle Scholar
  8. 8.
    Hekimian G, Khandoudi N, Feuvray D, Beigelman PM: Abnormal cardiac rhythm in diabetic rats. Life Sci 37: 547–551, 1985PubMedCrossRefGoogle Scholar
  9. 9.
    Kusama Y, Hearse DJ, Avkiran M: Diabetes and susceptibility to reperfusion-induced ventricular arrhythmias. J Mol Cell Cardiol 24: 411–421, 1992PubMedCrossRefGoogle Scholar
  10. 10.
    Tani M, Neely JR: Hearts from diabetic rats are more resistant to in vitro ischemia: Possible role of altered Ca2+metabolism. Circ Res 62: 931–940, 1988PubMedCrossRefGoogle Scholar
  11. 11.
    Tosaki A, Engelman DT, Engelman RM, Das DK: The evolution of diabetic response to ischemia/reperfusion and preconditioning in isolated working rat hearts. Cardiovasc Res 31: 526–536, 1996PubMedGoogle Scholar
  12. 12.
    Feuvray D, Lopaschuk GD: Controversies on the sensitivity of the diabetic heart to ischemic injury: The sensitivity of the diabetic heart to ischemie injury is decreased. Cardiovasc Res 34: 113–120, 1997PubMedCrossRefGoogle Scholar
  13. 13.
    Ravingerova T, Stetka R, Volkovova K, Pancza D, Dzurba A, Ziegelhoffer A, Styk J: Acute diabetes modulates response to ischemia in isolated rat heart. Mol Cell Biochem 210: 143–151, 2000PubMedCrossRefGoogle Scholar
  14. 14.
    Ravingerová T, Neckář J, Kolář F, Styk J: Response to myocardial ischemia in the diabetic rats in vivo: Are they more or less susceptible to ischemia? J Mol Cell Cardiol 33: A99, 2001CrossRefGoogle Scholar
  15. 15.
    Ravingerová T, Neckar J, Kolář F, Štetka R, Volkovová K, Ziegelhoffer A, Styk J: Ventricular arrhythmias following coronary artery occlusion in rats: Is diabetic heart less or more sensitive to ischemia? Basic Res Cardiol 96: 160–168, 2001PubMedCrossRefGoogle Scholar
  16. 16.
    Curtis MJ: Characterisation, utilisation and clinical relevance of isolated perfused heart models of ischemia-induced ventricular fibrillation. Cardiovasc Res 39: 194–215, 1998PubMedCrossRefGoogle Scholar
  17. 17.
    Neckář J, Papoušek F, Nováková O, Ošt’ádal B, Kolář F: Cardioprotective effects of chronic hypoxia and ischaemic preconditioning are not additive. Basic Res Cardiol: 97: 161–167, 2002PubMedCrossRefGoogle Scholar
  18. 18.
    Walker MJA, Curtis MJ, Hearse DJ, Campbell RWF, Janse MJ, Yellon DM, Cobbe SM, Coker SJ, Harness JB, Harron DWG, Higgins AJ, Julian DJ, Lab MJ, Manning AS, Northover BJ, Parratt JR, Riemersma RA, Riva E, Rüssel DC, Sheridan DJ, Winslow E, Woodward B: The Lambeth conventions: Guidelines for the study of arrhythmias in ischemia, infarction, and reperfusion. Cardiovasc Res 22: 447–455, 1988PubMedCrossRefGoogle Scholar
  19. 19.
    Ganguly PK, Pierce GN, Dhalla KS, Dhalla NS: Defective sarcoplasmic reticular calcium transport in diabetic cardiomyopathy. Am J Physiol 244: E528–E535, 1983PubMedGoogle Scholar
  20. 20.
    Dhalla NS, Pierce GN, Panagia V, Singal PK, Beamish RE: Calcium movements in relation to heart function. Basic Res Cardiol 77: 117–139, 1982PubMedCrossRefGoogle Scholar
  21. 21.
    Curtis MJ, Hearse DJ: Ischemia-induced and reperfusion-induced arrhythmias differ in their sensitivity to potassium: Implications for the mechanisms of initiation and maintenance of ventricular fibrillation. J Mol Cell Cardiol 21: 21–40, 1989PubMedCrossRefGoogle Scholar
  22. 22.
    Shimoni Y, Severson D, Giles W: Thyroid status and diabetes modulate regional differences in potassium currents in rat ventricle. J Physiol (Lond) 488: 673–688, 1995Google Scholar
  23. 23.
    Rodrigues B, Cam MC, McNeill JH: Myocardial substrate metabolism: Implications for diabetic cardiomyopathy. J Mol Cell Cardiol 27: 169–179, 1995PubMedCrossRefGoogle Scholar
  24. 24.
    Goto M, Tsuchida A, Liu Y, Cohen MV, Downey JM: Transient inhibition of glucose uptake mimics ischemic preconditioning by salvaging ischemic myocardium in the rabbit heart. J Mol Cell Cardiol 27: 1883–1894, 1995PubMedCrossRefGoogle Scholar
  25. 25.
    Khandoudi A, Bernard M, Cozzone P, Feuvray D: Intracellular pH and role of Na+/H+ exchange during ischemia and reperfusion of normal and diabetic rat hearts. Cardiovasc Res 24: 873–878, 1990PubMedCrossRefGoogle Scholar
  26. 26.
    Pierce GN, Ramjiawan B, Dhalla NS, Ferrari R: Na+/H+ exchange in cardiac sarcolemmal vesicles isolated from diabetic rats. Am J Physiol 258: H255–E261, 1990PubMedGoogle Scholar
  27. 27.
    Meldrum DR, Cleveland JC Jr, Sheridan BC, Rowland RT, Banerjee A, Harken AH: Cardiac preconditioning with calcium: Clinically accessible myocardial protection. J Thorac Cardiovasc Surg 112: 778–786, 1996PubMedCrossRefGoogle Scholar
  28. 28.
    Murry CE, Jennings RB, Reimer KA: Preconditioning with ischemia: A delay of lethal cell injury in ischemie myocardium. Circulation 74: 1124–1136, 1986PubMedCrossRefGoogle Scholar
  29. 29.
    Liu GS, Downey JM: Preconditioning against infarction in rat heart does not involve pertussis toxin sensitive G protein. Cardiovasc Res 27: 608–611, 1993PubMedCrossRefGoogle Scholar
  30. 30.
    Cave AC: Preconditioning induced protection against postischemic contractile dysfunction: Characteristics and mechanisms. J Mol Cell Cardiol 27: 969–979, 1995PubMedCrossRefGoogle Scholar
  31. 31.
    Vegh A, Komori S, Szekeres L, Parratt JR: Antiarrhythmic effects of preconditioning in anaesthetised dogs and rats. Cardiovasc Res 26: 487–495, 1992PubMedCrossRefGoogle Scholar
  32. 32.
    Mitchell MB, Meng X, Ao L, Brown JM, Harken AH, Banerjee A: Preconditioning of isolated rat heart is mediated by protein kinase C. Circ Res 76: 73–81, 1995PubMedCrossRefGoogle Scholar
  33. 33.
    Malhotra A, Reich D, Reich D, Nakouzi A, Sanghi V, Geenen DL, Buttrick PM: Experimental diabetes is associated with functional activation of protein kinase Ce and phosphorylation of troponin I in the heart, which are prevented by angiotensin II receptor blockade. Circ Res 81: 1027–1033, 1997PubMedCrossRefGoogle Scholar
  34. 34.
    Moon CH, Jung JS, Lee SH, Baik EJ: Protein kinase C inhibitors abolish the increased resistance of diabetic rat heart to ischemia-reperfusion injury. Jpn J Physiol 49: 409–415, 1999PubMedCrossRefGoogle Scholar
  35. 35.
    Noma A: ATP-regulated K+ channels in cardiac muscle. Nature 305: 147–148, 1983PubMedCrossRefGoogle Scholar
  36. 36.
    Spinelli W, Sorota S, Siegal M, Hoffman BF: Antiarrhythmic actions of the ATP-regulated K+current activated by pinacidil. Circ Res 68: 1127–1137, 1991PubMedCrossRefGoogle Scholar
  37. 37.
    Tan HL, Mazon P, Verberne HJ, Sleeswijk ME, Coronel R, Opthof T, Janse M: Ischemie preconditioning delays ischemia induced cellular electrical uncoupling in rabbit myocardium by activation of ATP sensitive potassium channels. Cardiovasc Res 27: 644–651, 1993PubMedCrossRefGoogle Scholar
  38. 38.
    Smith JM, Wahler GM: ATP-sensitive potassium channels are altered in ventricular myocytes from diabetic rats. Mol Cell Biochem 158:43–51, 1996PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York  2003

Authors and Affiliations

  • Táňa Ravingerová
    • 2
  • Jan Neckář
    • 1
  • František Kolář
    • 2
  1. 1.Institute of Physiology, Academy of Sciences of the Czech RepublicCentre for Experimental Cardiovascular ResearchPragueCzech Republic
  2. 2.Institute for Heart ResearchSlovak Academy of SciencesBratislavaSlovak Republic

Personalised recommendations